SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-23-020510
Filing Date
2023-05-10
Accepted
2023-05-10 16:07:27
Documents
68
Period of Report
2023-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q cyt-20230331.htm   iXBRL 10-Q 1521539
2 EX-10.2 cyt-ex10_2.htm EX-10 135118
3 EX-31.1 cyt-ex31_1.htm EX-31 20977
4 EX-31.2 cyt-ex31_2.htm EX-31 20953
5 EX-32.1 cyt-ex32_1.htm EX-32 11955
6 EX-32.2 cyt-ex32_2.htm EX-32 11941
  Complete submission text file 0000950170-23-020510.txt   6324129

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cyt-20230331_def.xml EX-101.DEF 134058
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cyt-20230331_pre.xml EX-101.PRE 262237
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT cyt-20230331_cal.xml EX-101.CAL 37584
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cyt-20230331.xsd EX-101.SCH 44066
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cyt-20230331_lab.xml EX-101.LAB 355582
62 EXTRACTED XBRL INSTANCE DOCUMENT cyt-20230331_htm.xml XML 1155695
Mailing Address 99 HAYDEN AVENUE BUILDING B, SUITE 450 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE BUILDING B, SUITE 450 LEXINGTON MA 02421 857-285-4140
Cyteir Therapeutics, Inc. (Filer) CIK: 0001662244 (see all company filings)

IRS No.: 455429901 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-40499 | Film No.: 23906364
SIC: 2834 Pharmaceutical Preparations